Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against ...

Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings per share (EPS) of $3.05 in first-quarter 2023, beating the Zacks Consensus Estimate and our model estimate of $2.95 and $2.92 ...

Vertex's painkiller was more effective than a placebo at reducing the intensity of pain after 48 hours in two late-stage studies on more than 1,000 patients who had abdominoplasties, also known as ...

Vertex non-opioid painkiller meets main goal in late-stage trials By Sriparna Roy and Khushi Mandowara January 30, 20247:56 AM PSTUpdated January 30, 2024 ...

Boston and London biotech company Vertex Pharmaceuticals is on a roll. In the past year and a half, Vertex worked with CRISPR Therapeutics to develop the first CRISPR treatment approved by the U.S ...